Alterations in the gonads of blue mussels Mytilus edulis exposed to paracetamol

Research output: Contribution to conferenceAbstract

Abstract

Paracetamol or acetaminophen is the most widely used pharmaceutical drug in the world and recent studies have reported its progressive increase in its concentrations in aquatic compartments. Meanwhile, scientific evidence suggests that pharmaceuticals can exert some important toxic effects to non-target aquatic species, due to their chemical and biological properties. The present study aims to assess the biological responses induced by paracetamol, at environmentally relevant levels, in the blue mussel Mytilus edulis, namely focusing on reproductive parameters. After 24 days laboratory exposure, seven potential target genes were selected to investigate toxicological effects in mussel gonads, and potential disturbances of the reproductive cycle. Results show the modulation of some important reproduction-related genes: estrogen receptor 2 (ER2), vitelline envelope zona pellucida domain 9 (V9), and vitellogenin (VTG). The variation in mRNA expression of four other genes involved in apoptosis (CASP8, HSP70, BCL2 and FAS) was also investigated. Histopathological alterations caused by paracetamol, together with its potential to act as a non-traditional endocrine disruptor are discussed.
Original languageEnglish
Publication statusPublished - 4 Nov 2019
EventSETAC Toronto – SETAC North America 40th Annual Meeting - Toronto, Toronto, Canada
Duration: 3 Nov 20197 Nov 2019
https://toronto.setac.org/

Conference

ConferenceSETAC Toronto – SETAC North America 40th Annual Meeting
CountryCanada
CityToronto
Period3/11/197/11/19
Internet address

Fingerprint Dive into the research topics of 'Alterations in the gonads of blue mussels Mytilus edulis exposed to paracetamol'. Together they form a unique fingerprint.

  • Cite this

    Koagouw, W. (2019). Alterations in the gonads of blue mussels Mytilus edulis exposed to paracetamol. Abstract from SETAC Toronto – SETAC North America 40th Annual Meeting, Toronto, Canada.